| PDF (542kB) |
- URN to cite this document:
- urn:nbn:de:bvb:355-epub-220489
- DOI to cite this document:
- 10.5283/epub.22048
Abstract
The effects of a nonselective beta-adrenergic blocking drug with beta-2 agonist activity (dilevalol 200 mg) on proteinuria and renal hemodynamics were evaluated in a double-blind crossover study versus an ACE inhibitor (enalapril 5 mg) in eight patients with glomerulonephritis, moderate renal function impairment and proteinuria greater than 1 g/24 hr. Patients were studied after a one week ...
Owner only: item control page